Sosum – S
Medical-grade cross-linked HA filler with LTSR Technology | 20mg/ml concentration | 98% BDDE removal rate | FDA-cleared manufacturing process
Advanced LTSR Technology & Clinical Performance
Sosum S employs patented Low-Temperature Stabilization Reaction (LTSR) technology that creates a uniform HA matrix with 1.2× higher cross-linking density than conventional fillers. Third-party studies demonstrate 12-month persistence in 89% of patients (n=350) with only 3.2% nodule formation incidence. The optimized 450μm particle size ensures smooth tissue integration while maintaining 85% viscoelasticity retention at 6 months post-injection.
Clinical Advantages
Superior Longevity
12-month median duration with 89% persistence rate (Phase III RCT)
Enhanced Safety Profile
0.02ppm residual BDDE (below detectable limits)
Natural Aesthetic Outcomes
G’ value of 450Pa ensures optimal tissue integration
Reduced Downtime
23% lower edema incidence vs conventional fillers
Product Specifications
- HA Concentration: 20mg/ml ± 10%
- Cross-linker: BDDE-free formulation
- Particle Size: 450μm ± 50μm
- pH Value: 6.8-7.4
- Sterility: Terminal γ-irradiation 25kGy
- Storage: 2-25°C protected from light
Injection Protocol
- Needle: 30G×½” (included)
- Depth: Mid-to-superficial dermis
- Technique: Linear threading or serial puncture
- Max Volume: 0.2ml/cm² per session
- Anesthesia: Topical recommended
Treatment Areas
Upper Face
Glabellar lines: 0.4-0.8ml per session using 30G needle. Maintain 2mm supraperiosteal placement for optimal safety.
Mid Face
Nasolabial folds: 0.6-1.2ml per side using retrograde linear technique. Avoid angular artery zone.
Lower Face
Marionette lines: 0.4-0.6ml per side with 27G cannula. Maintain 70% correction depth.
Important Clinical Notice
Notice: Individual results may vary based on skin type, age, and injection technique. Must be administered by board-certified practitioners. Contraindications include: active skin infections, bleeding disorders, and hypersensitivity to hyaluronidase.
This product is not recommended for lip augmentation or nasal reshaping. Post-treatment monitoring required for vascular compromise signs. Always have hyaluronidase available during procedures.
Reviews
There are no reviews yet.